(Q40873481)

24 September 2017

Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case). (English)

1 reference

24 September 2017

1 reference

1 reference

Hobbs CB

1

1 reference

24 September 2017

Miller AL

series ordinal

2

1 reference

24 September 2017

Thornley JH

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1965

1 reference

Postgraduate Medical Journal

24 September 2017

1 reference

24 September 2017

41

1 reference

24 September 2017

479

1 reference

24 September 2017

563-565

1 reference

The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.

24 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2483044

INITIAL EXPERIENCE WITH THROMBOTEST

24 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2483044

[Factors which can influence coumarin therapy.]

25 September 2017

1 reference

12 December 2020

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements

1 reference

12 December 2020

Observations on sodium D-thyroxine as a hypocholesteremic agent in persons with hypercholesteremia with and without ischemic heart disease

1 reference

12 December 2020

Effect of anticoagulant therapy upon aspirin-induced gastrointestinal bleeding

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.41.479.563

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

5827674

1 reference